HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Marjo van Puijenbroek Selected Research
Marjo van Puijenbroek Research Topics
Disease
11
Neoplasms (Cancer)
06/2010 - 02/2004
8
Colorectal Neoplasms (Colorectal Cancer)
09/2009 - 02/2004
3
Adenoma (Adenomas)
03/2011 - 01/2004
2
Colonic Neoplasms (Colon Cancer)
03/2011 - 12/2008
2
Pancreatic Neoplasms (Pancreatic Cancer)
01/2010 - 09/2003
2
Microsatellite Instability
02/2007 - 02/2006
2
Parathyroid Neoplasms (Parathyroid Neoplasm)
10/2004 - 01/2004
1
Carcinoma (Carcinomatosis)
03/2011
1
Aneuploidy (Aneuploid)
12/2008
1
Chromosome Aberrations (Chromosome Abnormalities)
12/2008
1
Carcinogenesis
10/2007
1
Hyperplasia
01/2004
Drug/Important Bio-Agent (IBA)
4
Calcibiotic Root Canal Sealer
IBA
06/2010 - 02/2004
4
Proteins (Proteins, Gene)
FDA Link
10/2007 - 10/2004
3
HLA Antigens (Human Leukocyte Antigens)
IBA
09/2009 - 10/2006
2
Paraffin
IBA
01/2010 - 11/2005
1
Protein Tyrosine Phosphatases
IBA
03/2011
1
Biomarkers (Surrogate Marker)
IBA
03/2011
1
Monomeric GTP-Binding Proteins
IBA
01/2010
1
Formaldehyde (Formol)
FDA Link
01/2010
1
Mitogen-Activated Protein Kinases
IBA
01/2010
1
DNA Repair Enzymes
IBA
09/2009
1
Keratins (Keratin)
IBA
12/2008
1
Vimentin
IBA
12/2008
1
DNA (Deoxyribonucleic Acid)
IBA
12/2008
1
Methyltransferases
IBA
10/2007
1
beta Catenin
IBA
10/2007
1
Neoplasm Antigens (Tumor Antigens)
IBA
02/2007
1
Peptides (Polypeptides)
IBA
02/2007
1
Suspensions
IBA
10/2006
1
Monoclonal Antibodies
IBA
10/2006
1
Isoantigens (Alloantigen)
IBA
10/2006
1
HLA-A Antigens (HLA-A)
IBA
10/2006
1
Mismatch Repair Endonuclease PMS2
IBA
02/2006
1
Antibodies
IBA
02/2006
1
human PMS2 protein
IBA
02/2006
1
Class 3 Receptor-Like Protein Tyrosine Phosphatases
IBA
11/2005
1
Amyloid beta-Protein Precursor (Amyloid Protein Precursor)
IBA
10/2004
1
Cadherins (E-Cadherin)
IBA
10/2004
1
Histones (Histone)
IBA
10/2004
1
Calcium-Sensing Receptors
IBA
01/2004
1
Cyclin D1
IBA
01/2004
1
A 19
IBA
09/2003
Therapy/Procedure
1
Immunotherapy
10/2006